Clinical Trial Update: Pegaspargase and Methotrexate Based Regimens for Newly Diagnosed Extranodal NK/T Cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 study evaluating pegaspargase- and methotrexate-based regimens for newly diagnosed nasal-type extranodal NK/T-cell lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extranodal Nk T-cell Lymphoma Nasal Type

Drugs mentioned

• METHOTREXATE (METHOTREXATE)
• Pegaspargase (pegaspargase)

Snippet

Sponsor: Ruijin Hospital | Conditions: Nasal Type Extranodal NK/T-Cell Lymphoma | Phase 2 | Status: COMPLETED